Scenic founders publish paper in Science Signaling

Today Scenic founders Sebastian Nijman and Thijn Brummelkamp published a paper in Science Signaling describing the use of Cell-Seq technology to interrogate the mTOR-pathway, a key energy sensing pathway. The publication further demonstrates the robustness of the platform even when employed in different laboratories and the power of comparing different Cell-Seq maps.